|
|
Post by peppy on Jan 23, 2019 19:04:07 GMT -5
I have something to say, and a question. I am going to type it in volume, I am starting to think the best use of Dr. Kendalls time would be to get afrezza (insulin human) FDA ruled generic insulin and made available over the counter. What do you think? Just talking, If Afrezza were over the counter selling for say, the Direct Purchase Program Prices; What do you think the market would be?
The type one's that want to have Afrezza for corrections could have it. type twos could have it.
Direct purchase is, For the first 1,000 registrants under this initial Direct Purchase Program Offer, prices are guaranteed for 12 months from time of first fill. Currently, eligible, enrolled patients pay:
$120 for a single 90 count box of 4, 8 or 12 Unit Afrezza Cartridges or $199 for any 180 count Afrezza combination box of 4, 8, and/or 12 Units.
Program is facilitated by Eagle Pharmacy, LLC. Participants are required to register directly with Eagle Pharmacy.
|
|
|
|
Post by mytakeonit on Jan 23, 2019 19:17:57 GMT -5
I agree and I think Mike C put this special out as a test market. It will be interesting in the coming months. Hey, maybe I should buy some more shares.  Or, did I already??? I better ask hellodolly ... |
|
|
|
Post by MnkdWASmyRtrmntPlan on Jan 23, 2019 19:21:17 GMT -5
Peppy, why do you think that doing that would allow Dr. K to get afrezza FDA ruled generic insulin? I am missing the connection.
|
|
|
|
Post by brotherm1 on Jan 23, 2019 20:41:55 GMT -5
If I remember correclty agedhippie mentioned before that the only reason the old insulins are OTC is because they were grandfathered in and now days the FDA probably would not approve them to be, and thus neither would they approve Afrezza to be.
|
|
|
|
Post by goyocafe on Jan 23, 2019 20:49:50 GMT -5
If I remember correclty agedhippie mentioned before that the only reason the old insulins are OTC is because they were grandfathered in and now days the FDA probably would not approve them to be, and thus neither would they approve Afrezza to be. Does the government, including the FDA, want their cake and eat it too? If they want the game to change, then change the rules. |
|
|
|
Post by peppy on Jan 23, 2019 20:55:41 GMT -5
Peppy, why do you think that doing that would allow Dr. K to get afrezza FDA ruled generic insulin? I am missing the connection. check me. Afrezza is made using NPH HUMAN INSULIN (rDNA ORIGIN) www.accessdata.fda.gov/drugsatfda_docs/label/2013/018781s121lbl.pdfHumulin N and Novolin N are both brand names for the same drug, called insulin NPH. Insulin NPH is an intermediate-acting insulin. ... You do not need a prescription to buy Novolin N or Humulin N from the pharmacy. However, you do need to talk to your doctor before you start using it. Kendall Most recently, he served as Research Physician and Vice President of Global Medical Affairs for Lilly Diabetes, and led all medical affairs activities and guided research and development strategy across multiple geographies. During this time, Dr. Kendall worked to re-establish Lilly Diabetes as a world class medical organization — and added to his extensive experience with both injected and mealtime insulins, as well as devices and continuous glucose monitors. Prior to Eli Lilly, Dr. Kendall served as Chief Scientific and Medical Officer at the American Diabetes Association, where he was responsible for all medical affairs, medical education, research, outcomes, and medical policy activities. Earlier in his career, Dr. Kendall served as Medical Director at the International Diabetes Center, and the Park Nicollet Clinic, as well as at Amylin Pharmaceuticals. Dr. Kendall received his M.D. and completed his Post Graduate Medical Training at the University of Minnesota, and earned a B.A. in Biology from St. Olaf College. didn't something go through legislatively today on drug prices? you want to reduce the price of insulin, make afrezza OTC |
|
|
|
Post by peppy on Jan 23, 2019 20:59:48 GMT -5
If I remember correclty agedhippie mentioned before that the only reason the old insulins are OTC is because they were grandfathered in and now days the FDA probably would not approve them to be, and thus neither would they approve Afrezza to be. yes, however aged can run negative to change. |
|
|
|
Post by uvula on Jan 24, 2019 9:51:22 GMT -5
If it is OTC will insurance cover it? If not then people with insurance will end up paying more. The cheap promotional price probably does not cover the actual cost so the OTC price will be higher.
|
|
|
|
Post by bioexec25 on Jan 24, 2019 10:02:18 GMT -5
If it is OTC will insurance cover it? If not then people with insurance will end up paying more. The cheap promotional price probably does not cover the actual cost so the OTC price will be higher. They didn't used to cover OTC as I recall. But with all the wellness push going on there are more plans that do give a certain OTC allowance. www.humanapharmacy.com/resources/over-the-counter.cmd |
|
|
|
Post by bigchungus91354 on Jan 24, 2019 10:26:33 GMT -5
If it is OTC will insurance cover it? If not then people with insurance will end up paying more. The cheap promotional price probably does not cover the actual cost so the OTC price will be higher. Do we know what the formula is to derive the promotional price? For the Eagle pharmacy, the promotion is as low as $4 per day, how do they determine the actual consumer cost? |
|
|
|
Post by agedhippie on Jan 24, 2019 11:14:38 GMT -5
Peppy, why do you think that doing that would allow Dr. K to get afrezza FDA ruled generic insulin? I am missing the connection. check me. Afrezza is made using NPH HUMAN INSULIN (rDNA ORIGIN) www.accessdata.fda.gov/drugsatfda_docs/label/2013/018781s121lbl.pdfHumulin N and Novolin N are both brand names for the same drug, called insulin NPH. Insulin NPH is an intermediate-acting insulin. ... You do not need a prescription to buy Novolin N or Humulin N from the pharmacy. However, you do need to talk to your doctor before you start using it. Kendall Most recently, he served as Research Physician and Vice President of Global Medical Affairs for Lilly Diabetes, and led all medical affairs activities and guided research and development strategy across multiple geographies. During this time, Dr. Kendall worked to re-establish Lilly Diabetes as a world class medical organization — and added to his extensive experience with both injected and mealtime insulins, as well as devices and continuous glucose monitors. Prior to Eli Lilly, Dr. Kendall served as Chief Scientific and Medical Officer at the American Diabetes Association, where he was responsible for all medical affairs, medical education, research, outcomes, and medical policy activities. Earlier in his career, Dr. Kendall served as Medical Director at the International Diabetes Center, and the Park Nicollet Clinic, as well as at Amylin Pharmaceuticals. Dr. Kendall received his M.D. and completed his Post Graduate Medical Training at the University of Minnesota, and earned a B.A. in Biology from St. Olaf College. didn't something go through legislatively today on drug prices? you want to reduce the price of insulin, make afrezza OTC Afrezza uses Regular insulin rather than NPH (Novolin R or Humulin R) I haven't seen anything go through legislatively, but there is H.R. 366 to remove the co-pay from insulin for Medicare and Medicaid which was introduced in early January and last I aws is waiting to be scheduled with both the Commerce committee, and the Ways and Means committee. I think this has a fair chance of getting done if it gets out of committee because it's a hard one to vote against. Making Afrezza OTC would not change the price. Mannkind could drop the price to $50 per box tomorrow if they wanted to. The reason people buy OTC insulin now isn't because they could not get a prescription or that it's OTC, it's because it's cheap. Edit: I ought to add that I can see no way the FDA will make Afrezza OTC. |
|
|
|
Post by bobbyboy on Jan 24, 2019 12:05:49 GMT -5
Attention all shorts. Hurry, hurry MNKD is up 0.005. Finish the three martini lunch before things get out of hand. RJF.
|
|
|
|
Post by peppy on Jan 24, 2019 15:28:08 GMT -5
If it is OTC will insurance cover it? If not then people with insurance will end up paying more. The cheap promotional price probably does not cover the actual cost so the OTC price will be higher. Do we know what the formula is to derive the promotional price? For the Eagle pharmacy, the promotion is as low as $4 per day, how do they determine the actual consumer cost? here is the tidbit of only seen once information I have. When with sanofi, when the initial sanofi order was filled, that turned out to be mostly for samples, the day of "riches". This was when Sanofi bore the all sales costs, I once saw to cost of 90 4 unit afrezza was $20 when all the lines were humming. The third line then added. When you put that in a formula and please report back? |
|
|
|
Post by peppy on Jan 24, 2019 15:48:12 GMT -5
agedhippie check me. Afrezza is made using NPH HUMAN INSULIN (rDNA ORIGIN) www.accessdata.fda.gov/drugsatfda_docs/label/2013/018781s121lbl.pdfHumulin N and Novolin N are both brand names for the same drug, called insulin NPH. Insulin NPH is an intermediate-acting insulin. ... You do not need a prescription to buy Novolin N or Humulin N from the pharmacy. However, you do need to talk to your doctor before you start using it. Kendall Most recently, he served as Research Physician and Vice President of Global Medical Affairs for Lilly Diabetes, and led all medical affairs activities and guided research and development strategy across multiple geographies. During this time, Dr. Kendall worked to re-establish Lilly Diabetes as a world class medical organization — and added to his extensive experience with both injected and mealtime insulins, as well as devices and continuous glucose monitors. Prior to Eli Lilly, Dr. Kendall served as Chief Scientific and Medical Officer at the American Diabetes Association, where he was responsible for all medical affairs, medical education, research, outcomes, and medical policy activities. Earlier in his career, Dr. Kendall served as Medical Director at the International Diabetes Center, and the Park Nicollet Clinic, as well as at Amylin Pharmaceuticals. Dr. Kendall received his M.D. and completed his Post Graduate Medical Training at the University of Minnesota, and earned a B.A. in Biology from St. Olaf College. didn't something go through legislatively today on drug prices? you want to reduce the price of insulin, make afrezza OTC rather than NPH ( Novolin R or Humulin R)I haven't seen anything go through legislatively, but there is H.R. 366 to remove the co-pay from insulin for Medicare and Medicaid which was introduced in early January and last I aws is waiting to be scheduled with both the Commerce committee, and the Ways and Means committee. I think this has a fair chance of getting done if it gets out of committee because it's a hard one to vote against. Making Afrezza OTC would not change the price. Mannkind could drop the price to $50 per box tomorrow if they wanted to. The reason people buy OTC insulin now isn't because they could not get a prescription or that it's OTC, it's because it's cheap. Edit: I ought to add that I can see no way the FDA will make Afrezza OTC. I am shaking my head I made the mistake once again. I knew I needed you to check me. insulin regular human (Rx, OTC)reference.medscape.com/drug/humulin-r-novolin-r-insulin-regular-human-999007I say we need to shoot for the stars here. |
|
|
|
Post by peppy on Jan 24, 2019 16:21:54 GMT -5
MNKD Nasdaq real time volume, 693,193 shares. MNKD Nasdaq summary volume, 1,015,708 shares. MNKD $1.28. +0.01. +0.78% www.nasdaq.com/symbol/mnkd |
|
Or, did I already??? I better ask hellodolly ...
